| Consumer Optical Co Inc | |
|
1426 Altamont Ave, Schenectady, NY 12303-2979 | |
| (518) 355-0795 | |
| (518) 355-1208 |
| Full Name | Consumer Optical Co Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1426 Altamont Ave, Schenectady, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043324775 | NPI | - | NPPES |
| 1034 | Other | NY | CDPHP |
| J100354592 | Other | NY | CONSUMER PTAN |
| 1285670018 | Other | NPI | |
| 0393490001 | Other | NY | DMERC PTAN |
| 200051441 | Other | NY | MVP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Albert M Morier |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285670018 PECOS PAC ID: 1052379351 Enrollment ID: I20050105000734 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Provider Name | Rocco F Loccisano |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1316963119 PECOS PAC ID: 4688632987 Enrollment ID: I20050105000757 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Provider Name | Thomas G Morrissey |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1750495453 PECOS PAC ID: 0042278343 Enrollment ID: I20050105000794 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Provider Name | Rachel M Mccann |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1699938191 PECOS PAC ID: 5395892632 Enrollment ID: I20090402000442 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Provider Name | Robert J Mcclure |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1215997549 PECOS PAC ID: 3375730039 Enrollment ID: I20101207000520 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Provider Name | Yasmin Aly El-hag |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134605603 PECOS PAC ID: 5092069716 Enrollment ID: I20181116000382 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Provider Name | Katrina Karpinski |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295350403 PECOS PAC ID: 2264833417 Enrollment ID: I20210625001938 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Consumer Optical Co Inc 1426 Altamont Ave, Schenectady, NY 12303-2979 Ph: (518) 355-0795 | Consumer Optical Co Inc 1426 Altamont Ave, Schenectady, NY 12303-2979 Ph: (518) 355-0795 |
News Archive
Scripps Research Institute scientists have made a significant leap forward in the drive to find a way to safely reprogram mature human cells and turn them into stem cells, which can then change into other cell types, such as nerve, heart, and liver cells. The ability to transform fully mature adult cells such as skin cells into stem cells has potentially profound implications for treating many diseases.
Third Rock Ventures, LLC today announced the formation of Jounce Therapeutics, Inc. with a $47 million Series A financing of the company. Jounce is focused on the discovery and development of first-in-class cancer immunotherapies designed to harness the patient's immune system to seek out and attack cancerous cells and tumors.
Political point-scoring over policies to control MRSA (meticillin-resistant Staphlococcus aureus) confuses cleanliness with the real failure in UK hospitals - poor hand hygiene and inadequate use of gloves, states an editorial in this week's issue of The Lancet.
The Focused Ultrasound Surgery Foundation has announced that eight leading manufacturers are among the initial sponsors of the 2nd International Symposium on MR-guided Focused Ultrasound, scheduled for October 17 through 20 near Washington, D.C.
› Verified 3 days ago
Dr. Lawrence Michael Cusma, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9 Gleason Rd, Schenectady, NY 12302 Phone: 518-399-6368 Fax: 518-399-6372 | |
Paloma Salam Od P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 9 Gleason Rd, Schenectady, NY 12302 Phone: 518-399-6368 Fax: 518-399-6372 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 418b Balltown Rd, Schenectady, NY 12304 Phone: 518-243-5741 Fax: 518-382-2509 | |
Robert J Mcclure, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1426 Altamont Ave, Schenectady, NY 12303 Phone: 518-550-7953 Fax: 518-355-1208 | |
Schenectady Eyecare & Eyewear Optometrist Medicare: Medicare Enrolled Practice Location: 1417 Union St, Schenectady, NY 12308 Phone: 518-374-1882 Fax: 518-374-1777 | |
Dr. Albert M Morier, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1426 Altamont Ave, Schenectady, NY 12303 Phone: 518-355-0795 Fax: 518-355-1208 |